Peer-reviewedCC BY-NCCancer Letters
N6-Substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells
Related
- DOPA-Substituted KLVFFA Peptides Potently Inhibit Amyloid-β Aggregation and Mitigate Neurotoxicity
- Central relaxin-3/RXFP3 signaling potently drives orexigenic behaviors and attenuates cisplatin-induced anorexia and body weight loss
- Discovery of Tetra-Substituted Imidazole Inhibitors of Plasmin
- Extracellular adenosine triphosphate upregulates S100A4 expression and promotes the migration and invasion of breast cancer cells via P2Y2/SOX9 signaling
- Evaluation of 6-substituted coumarins as SARS-CoV-2 main protease inhibitors: enzymatic, cellular, and computational insights.
BibTeX
@article{liu2026n6substituted,
title = {{N6-Substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells}},
author = {Peng Liu and Liwei Zhao and Ximing Xu and Feng Liu and Wenchao Zhang and Cheng Zhou and Jing Chen and Yanlong Pan and Yuping Du and Jinbo Yang and Qin Wang},
journal = {Cancer Letters},
year = {2026},
month = sep,
doi = {10.1016/j.canlet.2014.07.043},
url = {https://hal.science/hal-05772553v1},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - N6-Substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cells
AU - Peng Liu
AU - Liwei Zhao
AU - Ximing Xu
AU - Feng Liu
AU - Wenchao Zhang
AU - Cheng Zhou
AU - Jing Chen
AU - Yanlong Pan
AU - Yuping Du
AU - Jinbo Yang
AU - Qin Wang
PY - 2026
DA - 2026/09/30
JO - Cancer Letters
DO - 10.1016/j.canlet.2014.07.043
UR - https://hal.science/hal-05772553v1
SN - 0304-3835
ER -